Osama Abdel Mohimen Mohamed

Spécialisation: Oncologist/mammologist
18 années d'expérience
Parle:
Arabic, English
Consultations en ligne : disponibles
Espace de travail: Egypte, Caire, Hôpitaux oncologiques internationaux Shefaa Al Orman
Leads a hematology unit and is a member of ESMO, ASBMT, and ASH.
Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Explorez les forfaits avec le Dr Osama Abdel Mohimen Mohamed

Sélectionner la procédure

greffe de moelle osseuse

$15,000

par package

Le forfait comprend une gamme standard de services médicaux proposés par la clinique ainsi que des avantages supplémentaires comme l'hébergement, le transfert, etc.

Consultation en ligne avec Osama Abdel Mohimen Mohamed

Pratique et facile

100 % sécurisé et confidentiel

$50

Services du médecin

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

Procedures performed:

Head of hematology unit at Shefaa Al Orman oncology hospitals.
Diagnosis and management of the following cases:

 Acute leukemia: Aggressive cancers of the blood and bone marrow requiring immediate and intensive chemotherapy.

 Chronic leukemia: Slower-growing cancers that may be managed with long-term oral therapies.

 Lymphomas: Cancers of the lymphatic system, which can present in various forms and require tailored treatment approaches.

 Myeloma: A cancer of plasma cells in the bone marrow, often managed with a combination of novel agents and, in eligible patients, stem cell transplantation.

 Myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs): A group of disorders affecting the production of blood cells in the bone marrow.

Can treat and manage complications for all solid tumors.

- 2006-2007: House Officer - Kasr El Ainy Hospital, Cairo University, Egypt, Rotations included Emergency Department, Obstetrics and Gynecology, General Surgery, General medicine, Pediatrics, and ICU.

- 2008-2010: Medical Oncology Resident - National Cancer Institute, Cairo University, Egypt.

- 2011-2014: demonstrator of Medical Oncology National Cancer Institute, Cairo University, Egypt.

- 2014-2022: Assistant Lecturer - National Cancer Institute, Cairo University, Egypt.

- 2011-2016: Medical Oncology Specialist – Al Salam international hospital, inpatient and outpatient units.

- 2011-2013 Medical Oncology Specialist – Al Molalmen hospital, inpatient and outpatient units.

- 2015-2016 Medical Oncology Specialist – BAHEYA oncology center (NGO), Egypt.

- 2016-2019: Medical Oncology Specialist – Shefa El Orman Hospital (NGO), Luxor, Egypt

- 2019 - Now: Oncology consultant, Medical Oncology department, Shefa El Orman Hospital (NGO), Luxor, Egypt

- 2019 - Now: hematology consultant, Medical Oncology department, Shefa El Orman Hospital (NGO), Luxor, Egypt

Memberships:

- 2008-Present: European Society of Medical Oncology (ESMO)

- 2009: American Society of bone marrow transplantation (ASBMT)

- 2010: American Society of Hematology (ASH)